Search by Drug Name or NDC
NDC 50268-0331-12 Flucytosine 250 mg/1 Details
Flucytosine 250 mg/1
Flucytosine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is FLUCYTOSINE.
Product Information
NDC | 50268-0331 |
---|---|
Product ID | 50268-331_0e88b79b-c69b-3c90-e063-6394a90a294f |
Associated GPIs | 11000020000105 |
GCN Sequence Number | 009542 |
GCN Sequence Number Description | flucytosine CAPSULE 250 MG ORAL |
HIC3 | W3B |
HIC3 Description | ANTIFUNGAL AGENTS |
GCN | 42560 |
HICL Sequence Number | 004131 |
HICL Sequence Number Description | FLUCYTOSINE |
Brand/Generic | Generic |
Proprietary Name | Flucytosine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Flucytosine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | FLUCYTOSINE |
Labeler Name | AvPAK |
Pharmaceutical Class | Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA204652 |
Listing Certified Through | 2025-12-31 |
Package
NDC 50268-0331-12 (50268033112)
NDC Package Code | 50268-331-12 |
---|---|
Billing NDC | 50268033112 |
Package | 20 BLISTER PACK in 1 BOX (50268-331-12) / 1 CAPSULE in 1 BLISTER PACK (50268-331-11) |
Marketing Start Date | 2021-04-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |